Valkyrie Pharmaceutical Mix B 400 is presented in a 10-milliliter multidose vial and reportedly contains a 400-milligrams per milliliter blend of testosterone cypionate and boldenone undecylenate according to the label. Samples of this product were purchased from a European-based internet source between the dates of January 1, 2018 and February 28, 2018.
The samples were forwarded and received by the analytical laboratory SIMEC AG on February 28, 2018. SIMEC performed HPLC-UV quantitative dosage testing, ‘total aerobial microbiological count’ (TAMC) testing and ‘total yeast and mold count’ (TYMC) testing on March 9, 2018. The report was completed on July 11, 2018.
The product was identified with batch number “HGM9468” and an expiration date of November 2018.
Label claim: Valkyrie Pharmaceutical Mix B 400 has a label claim of 200 mg/ml testosterone cypionate and 200 mg/ml boldenone undecylenate.
Actual content: Valkyrie Pharmaceutical Mix B 400 was determined to have an actual content of 186.8 mg/ml testosterone cypionate and 174.4 mg/ml boldenone undecylenate.
No microbiological contamination was detected.
(The following images are photographs of the actual product that was submitted for testing.)
Does Valkyrie Pharmaceutical Mix B 400 really contain 200 milligrams of boldenone undecylenate and 200 milligrams of testosterone cypionate in each milliliter of solution? Is the product free of microbiological...
|Last Updated||October 12, 2018|